103 related articles for article (PubMed ID: 25489726)
61. Urine cell-free DNA as a promising biomarker for early detection of non-small cell lung cancer.
Ren S; Ren XD; Guo LF; Qu XM; Shang MY; Dai XT; Huang Q
J Clin Lab Anal; 2020 Aug; 34(8):e23321. PubMed ID: 32281142
[TBL] [Abstract][Full Text] [Related]
62. Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer.
Kumari S; Tewari S; Husain N; Agarwal A; Pandey A; Singhal A; Lohani M
Pathol Oncol Res; 2017 Jan; 23(1):91-97. PubMed ID: 27475647
[TBL] [Abstract][Full Text] [Related]
63. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer.
Sheng SL; Huang G; Yu B; Qin WX
Clin Chem; 2009 Sep; 55(9):1656-64. PubMed ID: 19628661
[TBL] [Abstract][Full Text] [Related]
64. The sensitivity and specifity of DR-70 immunoassay as a tumor marker for non-small cell lung cancer.
Arınç S; Kasapoğlu US; Akbay ÖM; Oruç Ö; Paker N
Tuberk Toraks; 2016 Mar; 64(1):34-40. PubMed ID: 27266283
[TBL] [Abstract][Full Text] [Related]
65. Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas.
Plönes T; Krohn A; Burger M; Veelken H; Passlick B; Müller-Quernheim J; Zissel G
PLoS One; 2012; 7(7):e41746. PubMed ID: 22848587
[TBL] [Abstract][Full Text] [Related]
66. GM2-activator protein: a new biomarker for lung cancer.
Potprommanee L; Ma HT; Shank L; Juan YH; Liao WY; Chen ST; Yu CJ
J Thorac Oncol; 2015 Jan; 10(1):102-9. PubMed ID: 25490003
[TBL] [Abstract][Full Text] [Related]
67. [Analysis of tumour-derived DNA in serum in advanced non-microcytic lung cancer: might it be a prognostic factor?].
Camps Herrero C; Bayo Zaera P; Sirera Pérez R; Sancho Salvador E; Blasco Cordellat A; Safont Aguilera MJ
Clin Transl Oncol; 2005 Apr; 7(3):122-6. PubMed ID: 15899220
[TBL] [Abstract][Full Text] [Related]
68. Lower serum levels of bilirubin in the newly diagnosed lung cancer patients: A case-control study in China.
Song Q; Wang B; Wang S; Zhang YM; Chen WH
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C168-72. PubMed ID: 26506870
[TBL] [Abstract][Full Text] [Related]
69. Quantification of Rac1 and Rac1b in serum of non small cell lung cancer by label free real time assay.
Sahu V; Gupta A; Kumar R; Gupta T; Mohan A; Dey S
Clin Chim Acta; 2016 Sep; 460():231-5. PubMed ID: 27425849
[TBL] [Abstract][Full Text] [Related]
70. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer.
Roth C; Kasimir-Bauer S; Pantel K; Schwarzenbach H
Mol Oncol; 2011 Jun; 5(3):281-91. PubMed ID: 21398193
[TBL] [Abstract][Full Text] [Related]
71. Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls.
Yoon KA; Park S; Lee SH; Kim JH; Lee JS
J Mol Diagn; 2009 May; 11(3):182-5. PubMed ID: 19324991
[TBL] [Abstract][Full Text] [Related]
72. Clinical significance of plasma free DNA in patients with non-small cell lung cancer.
Ma L; Du J; Sui Y; Wang S
J Int Med Res; 2019 Nov; 47(11):5593-5600. PubMed ID: 31547735
[TBL] [Abstract][Full Text] [Related]
73. Concentration and integrity indexes of urine cell-free DNA as promising biomarkers for early lung cancer diagnosis.
Ren S; Ren X; Guo H; Liang L; Wei K; Guo L; Qu X; Dai X; Huang Q
Per Med; 2021 Mar; 18(2):129-139. PubMed ID: 33565322
[No Abstract] [Full Text] [Related]
74. Clinical application of plasma mitochondrial DNA content in patients with lung cancer.
Chen J; Zhang L; Yu X; Zhou H; Luo Y; Wang W; Wang L
Oncol Lett; 2018 Dec; 16(6):7074-7081. PubMed ID: 30546441
[TBL] [Abstract][Full Text] [Related]
75. Clinical significance of serum S100A10 in lung cancer.
Hou YL; Zhang JH; Guo JB; Chen H
J Int Med Res; 2021 Oct; 49(10):3000605211049653. PubMed ID: 34605301
[TBL] [Abstract][Full Text] [Related]
76. Collaborative study for the evaluation of multiple simultaneous markers in lung cancer.
McIntire KR; Radovich BT; Gail MH; Go VL
Ann N Y Acad Sci; 1983; 417():435-42. PubMed ID: 6322660
[TBL] [Abstract][Full Text] [Related]
77. PCR-free, microfluidic single molecule analysis of circulating nucleic acids in lung cancer patient serum.
Liu KJ; Wang TH
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():8392-5. PubMed ID: 22256294
[TBL] [Abstract][Full Text] [Related]
78.
Zhang Y; Wang Z; Bai X; Xu Y
Int J Clin Exp Pathol; 2018; 11(10):4996-5001. PubMed ID: 31949576
[TBL] [Abstract][Full Text] [Related]
79. About MET expression and other biomarkers in non-small cell lung cancer.
Lambros L; Quintin-Roué I; Guibourg B; Uguen A
Virchows Arch; 2017 Nov; 471(5):685-686. PubMed ID: 28861615
[No Abstract] [Full Text] [Related]
80. Expression and clinical significance of tumor necrosis factor receptor-associated factor 1 in peripheral blood of patients with advanced lung cancer.
Li G; Wu T; Yang M
Am J Transl Res; 2023; 15(3):1871-1879. PubMed ID: 37056842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
